Insider Sell: EVP, GC & Corporate Secretary Delano Ladd Sells Shares of HealthEquity Inc (HQY)
Delano Ladd, the Executive Vice President, General Counsel & Corporate Secretary of HealthEquity Inc (NASDAQ:HQY), has sold 2,558 shares of the company on March 1, 2024, according to a recent SEC filing. The transaction was executed at an average price of $82.59 per share, resulting in a total value of $211,272.22.
HealthEquity Inc is a leading provider of health savings accounts (HSAs) and other health financial services. The company offers a range of solutions including HSAs, health reimbursement arrangements (HRAs), and other consumer-directed benefits for health plans, insurance companies, and individuals.
Over the past year, Delano Ladd has sold a total of 7,643 shares of HealthEquity Inc and has not made any purchases of the stock. The insider transaction history for the company shows a pattern of 14 insider sells and no insider buys over the same timeframe.
Shares of HealthEquity Inc were trading at $82.59 on the day of the insider's recent sale, giving the company a market capitalization of $6.999 billion. The price-earnings ratio of the company stands at 241.36, significantly above the industry median of 25.8 and the company's historical median price-earnings ratio.
According to the GuruFocus Value chart, with a stock price of $82.59 and a GF Value of $77.26, HealthEquity Inc is considered Fairly Valued with a price-to-GF-Value ratio of 1.07. The GF Value is an intrinsic value estimate that takes into account historical trading multiples, a GuruFocus adjustment factor based on past returns and growth, and future business performance estimates from Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
